Headquartered in Copenhagen, Sunstone Capital is an early-stage Life Science and Technology venture capital company investing in European start-up companies with strong potential to achieve global success in their markets. Since our establishment in 2007, we have built a strong portfolio currently totaling 50 companies and have completed several successful trade sales and IPOs. With approximately EUR 700 million in funds under management distributed on seven funds, Sunstone is today one of the leading and most active independent venture capital investors in the Nordic market.
Sunstone Capital
Venture CapitalHeadquartered in Copenhagen, Sunstone Capital is an early-stage Life Science and Technology venture capital company investing in European start-up companies with strong potential to achieve global success in their markets.
Founded 2007
Denmark
10-50 employees
Health Care, Pharmaceutical
Denmark
10-50 employees
Health Care, Pharmaceutical
36
Total Investments
21
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Health Care, Pharmaceutical
Funding Stage
Seed +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Sunstone Capital
Recent Investments (36)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jan 2024 | |
| Venture Round | •••••• | Oct 2023 | |
| Series A | •••••• | Mar 2023 | |
| Series A | •••••• | Jan 2023 | |
| Series C | •••••• | Dec 2022 | |
•••• ••••
|
Series A | •••••• | Feb 2022 |
|
•••• ••••
|
Series B | •••••• | Mar 2021 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2021 |
|
•••• ••••
|
Series B | •••••• | Jan 2021 |
|
•••• ••••
|
Series B | •••••• | Dec 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
